The way of SARS-CoV-2 vaccine development: success and challenges

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2 vaccines have been developed and several have been allowed for emergency use and rollout worldwide. With novel SARS-CoV-2 variants eme...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yetian, Dai, Tong, Wang, Bin, Zhang, Lei, Zeng, Ling-hui, Huang, Jun, Yan, Haiyan, Zhang, Long, Zhou, Fangfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575680/
https://www.ncbi.nlm.nih.gov/pubmed/34753918
http://dx.doi.org/10.1038/s41392-021-00796-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575680/
https://www.ncbi.nlm.nih.gov/pubmed/34753918
http://dx.doi.org/10.1038/s41392-021-00796-w

Ejemplares similares